| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 228,699 | 189,153 | 224,587 | 402,198 | | Cost of Revenue | 231,051 | 194,380 | 296,948 | 464,776 | | | Gross Profit | (2,352) | (5,227) | (72,361) | (62,578) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (44,204) | 20,437 | 34,452 | 4,253 | | Non Recurring |
-
|
-
|
-
| 94,844 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 41,852 | (25,664) | (106,813) | (161,675) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (853) | (2,187) | (2,977) | (12,598) | | Earnings Before Interest And Taxes | 40,999 | (27,851) | (109,790) | (174,273) | | Interest Expense | 8,004 | 7,976 | 8,043 | 6,037 | | Income Before Tax | 32,995 | (35,827) | (117,833) | (180,310) | | Income Tax Expense | (6,577) | 2,573 | (4,096) | 524,282 | | Minority Interest |
-
|
-
|
-
| (12,466) | | | | Net Income From Continuing Ops | 40,142 | (107,146) | (114,624) | (700,152) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 40,142 | (107,146) | (114,624) | (700,152) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $40,142 | ($107,146) | ($114,624) | ($700,152) |
|
0.13% Nasdaq 
0.32%
Income Statement
